Chapter 2: Very low to low risk
Chapter 3: Favorable intermediate risk
Chapter 4: Unfavorable intermediate risk
Chapter 5: High to very high risk
Chapter 6: Recurrence of prostate cancer
Chapter 7: Brachytherapy monotherapy
Chapter 8: Brachytherapy boost
